Enteric fever, predominantly caused by Salmonella typhi and S. paratyphi, continues to pose significant global health challenges. However, advancements in diagnostic methods and treatment strategies have brought about promising changes in managing this infectious disease. This article presents a comprehensive overview of these advancements for healthcare professionals.
Traditional culture methods have been supplemented with serological tests and molecular techniques. The Widal test, though commonly used, suffers from sensitivity and specificity issues. The Typhidot test and Tubex TF test offer better accuracy but are not without limitations. Molecular techniques such as Polymerase Chain Reaction (PCR) and Loop-Mediated Isothermal Amplification (LAMP) have emerged as reliable diagnostic tools, offering rapid, sensitive, and specific detection of S. typhi and S. paratyphi.
Treatment for enteric fever has evolved due to the rising antimicrobial resistance. Fluoroquinolones, the first-line treatment, have seen decreased efficacy due to resistant strains. The World Health Organization now recommends using ceftriaxone or azithromycin as first-line treatments. Vaccination also plays a crucial role in prevention, with the Ty21a and Vi polysaccharide vaccines providing significant protection.
Antimicrobial stewardship programs (ASPs) are increasingly recognized as essential in managing enteric fever. ASPs ensure optimal antibiotic use, minimizing the development of resistance. They also promote the use of rapid diagnostics to guide targeted therapy, reducing unnecessary broad-spectrum antibiotic use.
While challenges persist in managing enteric fever, advancements in diagnostic and treatment strategies offer hope. The integration of molecular diagnostics, new therapeutic guidelines, and antimicrobial stewardship programs can enhance patient outcomes and curb the spread of this infectious disease. It is crucial for healthcare professionals to stay abreast of these developments to provide optimal patient care.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation